Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cephalexin and amoxicillin-clavulanate in pulmonary tuberculosis
NCT05664568Phase 2Unknown
- Sponsor
- Western Sydney Local Health District
- Start
- Mar 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cefalexin, amoxicillin + clavulanate in pulmonary tuberculosis (TB), sponsored by Western Sydney Local Health District. Status: unknown.
02
Drugs
cefalexinamoxicillin + clavulanate
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT05664568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05664568.